Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about US FDA approve breakthrough therapy designation to AbbVie's Venetoclax
AbbVie, a research-based biopharmaceutical company, has been granted breakthrough therapy designation to Venetoclax by the US FDA for the treatment of chronic lymphocytic leukemia (CLL) in previously treated (relapsed/refractory) patients with the 17p deletion genetic mutation.
- Read more about Gujarat introduce India’s first mobile drug testing lab with an investment of Rs. 1 cr
By introducing mobile drug testing lab, making it the first state in the country to possess such a high tech on the go-spot-detecting drug testing laboratory. The state government invest Rs. 1 crore from the funds allocated to the Gujarat Food and Drug Control Administration (FDCA) for this purpose.
- Read more about Indian doctors evolve new surgical technique to treat severe drug resistant epilepsy
Doctors at the All India Institute of Medical Sciences (AIIMS), Delhi, have developed a novel technique of minimally invasive surgery to perform a complete unilateral hemispheric disconnection of the brain. This procedure is sometimes required for patients especially children who have severe drug resistant epilepsy.
18 May 2015

Opto Circuits introduce Powerheart G5 Automated External Defibrillator in US & Canadian markets

Opto Circuits' group company, Cardiac Science, launched newest automated external defibrillator (AED) to the US and Canadian markets. The Powerheart® G5 is the first AED to combine real-time CPR feedback, fully automatic shock delivery, variable escalating energy, and fast shock times.
- Read more about Pharma Sector to soon showcase New Drugs: Union health Min
The Indian pharmaceutical sector would soon be showcasing new drugs for malaria, oste porosis and diabetes, Union Minister for Science and Technology Harsh Vardhan said. The candidate drugs are currently undergoing clinical trials, he said.

[adsense:336x280:8701650588]
- Read more about Biocon chairman got 2nd Rank in 'Medicine Maker Power List 2015'
Biocon’s chairman and managing director Kiran Mazumdar-Shaw, got 2nd rank in ‘The Medicine Maker Power List' 2015, an index of the 100 most influential people across the globe in the field of medicine. The top 5 in ‘The Medicine Maker Power List’ are: Anthony Fauci, director, National Institute of Allergy and Infectious Diseases, USA, Kiran Mazumdar-Shaw, chairman & managing director, Biocon, Sir Andrew Witty, chief executive officer, GlaxoSmithKline, Arthur D. Levinson, chief executive officer, Calico and Heather Bresch, chief executive officer of Mylan.
- Read more about US FDA grant Roche's cobas KRAS mutation test for diagnostic use
The US Food and Drug Administration (FDA) has approved Roche's cobas KRAS mutation test for diagnostic use. The real-time PCR test is designed to identify KRAS mutations in tumour samples from metastatic colorectal cancer (mCRC) patients and aid clinicians in determining a therapeutic path for them.
- Read more about Jubilant Life net profit lowered by 56.8% in Q4, dividend at 300%
Jubilant Life Sciences has suffered drop during the fourth quarter ended March 2015 due to lower sales and its consolidated net profit declined sharply by 56.8 per cent to Rs.42.73 crore from Rs.98.81 crore in the corresponding period of last year. Its consolidated net sales also declined by 1.9 per cent to Rs.1,523 crore from Rs.1,552 crore. EBIDTA improved marginally to Rs.253.27 crore from Rs.250.86 crore. EPS declined to Rs.2.68 from Rs.6.20 in the last period. The company management recommended equity dividend of 300 % for the year 2014-15.
- Read more about India will share its part in first clinical study using stem cells to cure spinal cord injury
India will bea part of a first-of-its-kind clinical trial for treating spinal cord injury in humans through stem-cells involving 18 patients. The clinical trial is a part of a collaborative study conducted in China, Norway and America involving 240 patients. The pre-clinical trial of this project already completed in the US and also the first phase clinical trials in China involving 120 patients.
- Read more about India and Mongolia comes closer for Traditional Systems of Medicine and Homoeopathy
The Union Cabinet chaired by the Prime Minister, Shri Narendra Modi, today gave its approval for signing of a Memorandum of Understanding (MoU) for cooperation in the field of Traditional Systems of Medicine and Homoeopathy between India and Mongolia.